RAC1 and neoplasm: RH derivative 4F as a novel anthraquinone compound with better anti-tumor activity through the more stably binding to Rac1 and inhibiting Rac1 promoter activity in cells and down-regulating Rac1 protein expression (Li X. et al., 2020).